President’s Cancer Panel Examining Barriers to Care

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 9 No 11
Volume 9
Issue 11

BETHESDA, Md-The President’s Cancer Panel is conducting a series of seven regional meetings to explore the question, “Why don’t all Americans get the best available cancer care?” The panel is seeking to identify specific barriers to care and ways to overcome them.

BETHESDA, Md—The President’s Cancer Panel is conducting a series of seven regional meetings to explore the question, “Why don’t all Americans get the best available cancer care?” The panel is seeking to identify specific barriers to care and ways to overcome them.

The meetings, designed to gather information from all 50 states, will hear public testimony from people who have encountered barriers to obtaining cancer care and from physicians, nurses, social workers, patient advocates, and health care officials. The first meeting was held in Omaha, Nebraska, in June, and the last meeting will be held in Washington, DC, in May 2001.

Recent Videos
5 experts are featured in this series
2 experts are featured in this series.
5 experts are featured in this series
2 experts are featured in this series.
Taletrectinib showed improved efficacy in patients with ROS1-positive non–small cell lung cancer who were treatment-naïve.
“It’s a drug that I’m very comfortable with, and it is a drug I’ll likely use primarily in the first-line setting,” stated Jorge Nieva, MD, on taletrectinib in non–small cell lung cancer.
4 experts in this video
4 experts in this video
Those being treated for peritoneal carcinomatosis may not have to experience the complication rates or prolonged recovery associated with surgical options.
For patients with peritoneal carcinomatosis, integrating PIPAC into a treatment regimen does not interrupt their systemic therapy.